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Bone marrow stromal cells
Angiogenesis
A B S T R A C T
Certain biomaterials are capable of inducing the secretion of Vascular Endothelial Growth Factor (VEGF) from
cells exposed to their biochemical influence, which plays a vital role in stimulating angiogenesis. Looking for this
capacity, in this study three porous glasses were synthesized and characterized. Glass compositions (in mol-%)
were: 60SiO⁠2–(36-2x)CaO–4P⁠2O⁠5–xCuO–xSrO with x=0, 1 or 2.5, respectively, for B60, CuSr-1 or CuSr-2.5
glasses. Cu⁠2+ and Sr⁠2+ ions were added because of the reported biological capabilities of Cu⁠2+ as angiogenic
stimulator and Sr⁠2+ as osteogenic stimulator. The objective of this study was to determine the concentration of
the glass particles that, being out of the cytotoxic range, could increase VEGF secretion. The viability of culti-
vated bone marrow stromal cells (ST-2) was assessed. The samples were examined with light microscopy (LM)
after the histochemical staining for haematoxylin and eosin (HE). The biological activity of glasses was evaluated
in terms of the influence of the Cu⁠2+ and Sr⁠2+ ions on the cells. The dissolution products of CuSr-1 and CuSr-2.5
produced the highest secretion of VEGF from ST-2 cells after 48h of incubation. The combination of Cu⁠2+ and
Sr⁠2+ lays the foundation for engineering a bioactive glass than can lead to vascularized, functional bone tissue
when used in bone regeneration applications.
1. Introduction
Neovascularization is a critical step in bone repair and regeneration
as bone is a vascularized tissue which relies on the close interaction be-
tween blood vessels and bone cells [1]. Several signaling molecules are
involved in angiogenesis such as the Vascular Endothelial Growth Fac-
tor (VEGF), the basic fibroblast growth factor (bFGF), and various mem-
bers of the transforming growth factor beta (TGFβ) family. VEGF is a
signaling molecule secreted by hypertrophic chondrocytes and induces
angiogenesis from the perichondrium leading to the recruitment of os-
teoblasts, osteoclasts and haemotopoietic cells [2]. VEGF, as a single
agent, stimulates osteogenesis by activating osteoblasts and angiogene-
sis by activating endothelial cells to support bone repair [3, 4].
In the last decade, studies have shown that certain compositions of
bioactive glasses stimulate the production of angiogenic growth factors
such as VEGF both in vitro and in vivo [5–8]. In the last years novel
bioactive glasses containing mesopores, i.e. in the 2–10nm range, which
exhibit novel features not present in the classical melt-derived bioac-
tive glasses, have been developed by sol-gel methods [9]. These glasses
were first proposed in 1991 [10] and their ordered mesoporous vari-
ants, mesoporous bioactive glasses (MBGs), were first proposed in 2004
[11]. MBGs were further characterized by Wu and Chang [12] and
previous work in the field has been reviewed by Izquierdo-Barba and
Vallet-Regí [13]. MBGs exhibit high in vitro bioactivity and control-
lable drug delivery capability which can be exploited for various bio-
medical applications including cancer therapy. Compared with tradi-
tional sol-gel derived glasses, MBGs exhibit ordered arrangements of
mesopores and a very narrow pore size distribution [14, 15] These fea-
tures make MBGs more appropriate for the design of drug delivery and
stimulus-responsive systems [9, 13]. However, for their applications in
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bone regeneration, both families of bioactive glasses exhibit similar be-
havior after implantation.
On the other hand, the incorporation of therapeutic ions such as
lithium, boron, copper, strontium, magnesium, zinc, silver and others
in the composition of any of the three families of bioactive glasses
(i.e. melt-derived glasses, sol-gel derived glasses or MBGs), has been
shown to be beneficial in influencing several biological functions such
as osteogenesis, angiogenesis and anti-bacterial activity [16–19]. In this
sense, ions such as Sr⁠2+ improve osteoblast differentiation by coordi-
nating with various osteoblastic genes and they also have an effect on
osteoclastic activity [19–23]. In addition, copper ions have been known
for decades to stimulate angiogenesis and enhance the development of
blood vessels to construct a vascularized structure [7, 16, 24–27]. In this
context, the mechanisms by which cobalt ions (not investigated in this
article) and copper ions stimulate angiogenesis have been described in
literature [28, 29].
In this work, three new bioactive glasses with composition (in
mol-%) 60SiO⁠2–(36-2x)CaO–4P⁠2O⁠5–xCuO–xSrO with x=0, 1 or 2.5
were obtained by a wet chemistry based method. Table 1 shows the
compositions of the three glasses and the codes used to identify them.
For the undoped glass (free of CuO and SrO) the code chosen was B60 to
highlight its bioactive character and the SiO⁠2 content (60mol%). For the
other two glasses, their respective codes were CuSr-1 and CuSr-2.5 to
highlight their content in CuO and SrO. There is limited previous work
on Sr-Cu-containing MBGs based on the SiO⁠2-CaO binary system, e.g.
without P [30]. The present paper focuses on the evaluation of the se-
cretion of VEGF from mouse stromal cells (ST-2 cells) from bone mar-
row when cultured in the presence of the dissolution products of bioac-
tive glasses. The final aim of this study was to determine the concentra-
tion of the glass particles (size<32μm) that, being out of the cytotoxic
range, could increase VEGF secretion under the mentioned in vitro con-
ditions, highlighting the angiogenic effect of the glasses in relation to
the presence of Sr⁠2+ and Cu⁠2+ ions.
2. Experimental procedure
2.1. Glass synthesis
Glasses were synthesized by using the evaporation-induced self-as-
sembly (EISA) method [31]. The nonionic surfactant Pluronic® _ P123
(Sigma-Aldrich) was used as a structure-directing agent. Pluronic® is an
amphiphilic triblock copolymer having the sequence poly(ethylene ox-
ide)⁠20–poly(propylene oxide)⁠70–poly(ethylene oxide)⁠20. During synthe-
sis, 4.5g of Pluronic® P123 was dissolved (1h) in 85mL of ethanol with
1.12mL of 0.5N HNO⁠3. Every 3h interval other reactants were added
under continuous stirring in the order: tetraethyl orthosilicate (TEOS),
triethyl phosphate (TEP), calcium nitrate, cooper nitrate and strontium
nitrate (all the reactants of Sigma-Aldrich), keeping the flask covered
by a plastic paraffin film (Parafilm®) in the amounts indicated in Table
2. Following the EISA process, the sol was cast in a Petri dish for gela-
tion, which took 35h. Then, gels were aged for 7days at room tem-
perature. The dried gels were removed as a homogeneous, transpar-
ent membrane and heated at 700 °C for 3h to remove the surfactant
and nitrate groups, and to stabilize the resultant porous glasses under
atmospheric conditions. Obtained materials were milled and sieved to
Table 1
Composition (in mol%) of glasses investigated in this study.
Acronym SiO⁠2 CaO P⁠2O⁠5 CuO SrO
B60 60 36 4 – –
CuSr-1 60 34 4 1 1
CuSr-2.5 60 31 4 2.5 2.5
obtain grains of size<32μm giving rise to B60, CuSr-1 and CuSr-2.5
samples.
2.2. Glass characterization
The mesopore structure was evaluated by transmission electron mi-
croscopy (TEM) in a JEM-2100 microscope (JEOL), operating at 200kV,
equipped with an energy dispersive X-ray (EDX; Oxford INCA) mi-
croanalysis stage. Nitrogen adsorption–desorption isotherms at 77.35K
used to determine the textural properties were acquired using a ASAP
2020 porosimeter (Micromeritics). Before the adsorption measurements,
the samples were degassed under vacuum for 24h at 120 °C. The sur-
face area was obtained by applying the Brunauer–Emmett–Teller (BET)
method. The pore size distribution was determined by the Bar-
rett–Joyner–Halenda (BJH) method from the adsorption branch of the
isotherm [32]. Magic angle- spinning (MAS) and single-pulse solid-state
nuclear magnetic resonance (NMR) measurements were performed to
evaluate the different silicon and phosphorus environments in the syn-
thesized samples. The NMR spectra were recorded on an Advance 400
spectrometer (Bruker). Samples were spun at 10kHz for ⁠29Si and 6kHz
for ⁠31P. Spectrometer frequencies were set to 79.49 and 161.97MHz
for ⁠29Si and ⁠31P, respectively. Chemical shift values were referenced to
tetramethylsilane and H⁠3PO⁠4 for ⁠29Si and ⁠31P, respectively. All spectra
were obtained using a proton enhanced cross polarization (CP) method,
using a contact time of 1ms. The time periods between successive accu-
mulations were 5 and 4s for ⁠29Si and ⁠31P, respectively, and the number
of scans was 10.000 for all the spectra.
2.3. Cell culture
Cell culture experiments were performed according to the previously
described procedure [33–35]. A bone marrow stromal cell line (ST-2,
Deutsche Sammlung für Mikroorganismen und Zellkultur, Germany),
isolated from bone marrow of BC8 mice, was used for cell culture ex-
periments. Cells were cultured in RPMI 1640 medium (Gibco, Germany)
containing 10vol% FBS (Sigma-Aldrich, Germany) and 1vol% peni-
cillin/streptomycin (Sigma-Aldrich).
ST-2 cells were seeded for 24h at 100.000cells/mL. At the same
time, 0.1g of the three glass powders were added to 10mL culture me-
dia (without cells) and incubated separately for 24h at 37 °C. After 24h,
the supernatant was extracted and diluted into different concentrations
(0; 0.01; 0.1; 1 wt/vol) from all samples. The seeded ST-2 cells were
washed with Phosphate Buffered Saline (PBS) and the different dilutions
of supernatant from the pre-incubated granules were transferred to the
ST-2 cells for further 48h. In these tests, the cultured cells do not come
in direct contact with the glass granules, but only with the ionic disso-
lution products.
A WST-8 assay was carried out to evaluate the viability of the cul-
tivated cells, as described previously [33]. The samples were exam-
ined with light microscope (LM) after the histochemical staining using
haematoxylin and eosin (HE).
2.4. VEGF release
The amount of released VEGF from ST-2 cells into the cell culture
medium was measured by using a RayBio Human VEGF ELISA (En-
zyme-Linked Immunosorbent Assay) kit. This assay, for the quantitative
measurement of VEGF in cell culture supernatants, employs an antibody
specific for mouse VEGF coated on a 96-well plate. The changes of color
from blue to yellow are detected and the intensity of the color is mea-
sured at 450nm (Phomo, Anthos Mikrosysteme GmbH, Germany). The










Amount of reactants used in the glass synthesis and composition of the resultant glasses (in wt%) determined by EDX.
Sample TEOS (mL) TEP (mL) Ca(NO⁠3)⁠2·4H⁠2O (g) Cu(NO⁠3)⁠2·2.5H⁠2O (g) Sr(NO⁠3)⁠2 (g) SiO⁠2% CaO % P⁠2O⁠5 CuO % SrO %
B60 7.67 0.79 4.54 __ __ 62±2 34±1 4±1 __ __
CuSr-1 7.67 0.79 4.14 0.13 0.12 63±2 30±3 4±1 0.8±0.1 1.6±0.7
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2.5. Statistics
All in vitro results are presented using the mean value and stan-
dard deviation of six replicates of each sample type. All results were
normalized to 0 wt/vol. (=100%). The differences in analysis parame-
ters between the different samples and the different particle concen-
trations investigated were evaluated by one-way analysis of variance
(ANOVA). The level of statistical significance was defined at p<.05
(Origin 8.1G, Origin Lab Corporations, USA). The significance level was
set as p<.05=*, p<.01=** and p<.001=***. For comparison of
the mean values, the Tukey test was applied.
3. Results
3.1. Glass characterization
Fig. 1 shows TEM images and EDX spectra of the three synthesized
glasses B60, CuSr-1 and CuSr-2.5. TEM micrographs show the absence
of a mesoporosus order, although in some areas a worm-like mesopore
structure can be seen. On the other hand, EDX confirms the presence
of Si, Ca, P, Sr and Cu in the glasses in analogous amounts to the nom-
inal glass composition. The elemental weight-percentages obtained are
included in Table 2. The presence of Ni detected by EDX comes from
the Ni-grids used in these studies (because the Cu content in two of the
investigated glasses).
Nitrogen adsorption/desorption isotherms and pore size distribution
curves of B60, CuSr-1 and CuSr-2.5 are shown in Fig. 2. Inset tables
display the specific surface area (S⁠BET), pore diameter (D⁠P) and pore
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Fig. 2. Nitrogen adsorption-desorption isotherms (left) and pore size distributions (right) of B60, CuSr-1 and CuSr-2.5 samples. Inset tables display the most important textural properties
of the porous glasses: Surface area (S⁠BET), pore diameter (Dp) and Volume of pores (V⁠P).
volume (V⁠P) values for each sample. Isotherms can be identified as type
IV according to the IUPAC classification, typical of mesoporous solids
[36]. Moreover, the presence of H1 type hysteresis loops in the meso-
pore range indicated the existence of open ended cylindrical mesopores
with narrow pore size distributions [32, 37]. As observed, S⁠BET val-
ues ranged between 155m⁠2/g (CuSr-2.5) and 210m⁠2/g (CuSr-1) being
174m⁠2/g for B60. Such surface areas are of the same order of magni-
tude of those of traditional sol-gel derived glasses and somewhat lower
than that of MBGs. On the other hand, the highest values of D⁠P and V⁠P
were measured for B60 (6.0nm and 0.40cm⁠3/g, respectively) whereas
for CuSr-1 and CuSr-2.5 D⁠P and V⁠P were close to 4.0nm and 0.30cm⁠3/g.
⁠29Si solid-state MAS NMR measurements were performed to inves-
tigate the environments of the network former species at the atomic
level as shown in Fig. 3. Q⁠2, Q⁠3, and Q⁠4 represent the silicon atoms
denoted as Si* in (NBO)⁠2Si*–(OSi)⁠2, (NBO)Si*–(OSi)⁠3 and Si*(OSi) ⁠4
(NBO=non-bonding oxygen), respectively [38]. The chemical shifts
and the deconvoluted peak areas for each sample are shown. The sig-
nals in the −110ppm region come from Q⁠4 and those at −100ppm
come from Q⁠3. A resonance at approximately −92ppm comes from
Q⁠2, but for CuSr-1 and CuSr-2.5 samples, the resonance decreases to
−87ppm [39] due to the presence of Cu⁠2+ and Sr⁠2+ in the network.
⁠29Si-MAS-NMR spectroscopy was used to evaluate the network con-
nectivity (NC) of porous glasses as a function of chemical composition
(Q⁠n) (Fig. 3). B60 sample is characterized by a high percentage of Q⁠4
and Q⁠3 species and a NC of 3.20. The introduction of CuO and SrO
causes a slight decrease of NC relative to B60 sample, increasing the
percentage of Q⁠2 in detriment of Q⁠3. Therefore, when the concentra-
tion of CuO and SrO is increased in the glass, the NC decreased to 3.08
and 2.98 for CuSr-1 and CuSr-2.5 glasses, respectively. These samples
exhibit a higher amount of ion modifier that disrupts the mesophase
formation, leading to a depolymerized silica network [40]. This is be-
cause the amount of Ca⁠2+ necessary to act as a compensator of charge
is higher than that present in the sample because some of the Ca⁠2+
ions are involved in the Q⁠0 species of P. This is indicative that the
joint presence of Ca⁠2+ and PO⁠4⁠3−, results in amorphous calcium phos-
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Fig. 3. Solid-state ⁠29Si single-pulse MAS-NMR spectra of B60, CuSr-1 and CuSr-2.5 of B60,
CuSr-1 and CuSr-2.5 samples. The areas for the Q⁠n units were calculated by Gaussian
line-shape deconvolution and are displayed in green. (For interpretation of the references
to color in this figure legend, the reader is referred to the web version of this article.)
these materials, in agreement with a previously reported model [41,
42].
In addition, ⁠31P NMR spectroscopy was used to evaluate the local
environment of P atoms, thus elucidating the phosphate species con-
tained in the different samples (Fig. 4). Q⁠0 and Q⁠1 represent phospho
Fig. 4. Solid-state ⁠31P single-pulse MAS-NMR spectra of B60, CuSr-1 and CuSr-2.5 of B60,
CuSr-1 and CuSr-2.5 samples.
rus atoms (denoted by P*) in the PO⁠4⁠3− species of P*–(NBO)⁠4 and
(NBO)⁠3–P*–(OP), respectively. The spectra recorded by single pulse
show a signal at ~2ppm corresponding to Q⁠0 units present in the PO⁠4
⁠3− species [43]. The Full Width at Half Maximum (FWHM) for CuSr-2.5
and CuSr-1 samples are narrower than B60 indicating that the clusters
are larger and more crystalline with increasing content of Cu⁠2+ and
Sr⁠2+ ions. These results evidence that most of the P atoms are included
as independent PO⁠4⁠3− tetrahedra within the silica network, thus avoid-
ing polyphosphate formation. The orthophosphates would be balanced
with the divalent ions introduced in the system and the nature of these
cations seems to play an important role on the characteristics of the
phosphate clusters. Thus, Cu⁠2+ and Sr⁠2+ do not act as network formers
but as network modifiers [44].
3.2. Cell culture
Cell viability values of ST-2 cells cultured with the supernatant of
B60, CuSr-1 and CSr-2.5 glasses of different sizes and at different con-
centrations (0.01–1 wt/vol%) after 48h of incubation are shown in Fig.
5. Compared to the reference, B60 samples show a slight reduction in
cell viability whereas the 0.1 and 1 wt/vol% of Cu- and Sr- contain-
ing glasses were cytotoxic. There is a significant reduction of cell activ-
ity through the released products from the CuSr-1 and CuSr-2.5 parti-
cles. Similar results were obtained from LM images, as shown in Fig. 6.
The three dilutions of B60 and the 0.01 wt/vol% dilution of CuSr-1 and
Fig. 5. Cell viability of ST-2 cells treated with the supernatant of different concentrations
(0.01–1 wt/vol%) of B60, CuSr-1 and CuSr-2.5 bioactive glasses after 48h of incubation.
All results were normalized to 0 wt/vol% (=100%). Asterisks denote significant difference
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Fig. 6. Light Microscopy-images of ST-2 cells treated with the supernatant of different concentrations (0.01–1 wt/vol%) of B60, CuSr-1 and CuSr-2.5 bioactive glasses after 48h of incu-
bation.
CuSr-2.5 have no negative influence on cell morphology, whereas
higher concentrations, such 0.1 and 1 wt/vol%, were seen to disrupt the
cell layer formation.
3.3. VEGF release
In Fig. 7, the VEGF release from ST-2 cells cultured in the super-
natant of different dilutions of B60, CuSr-1 and CuSr-2.5 after 24h is
shown. Similar to the cell viability results and LM images, the different
dilutions of B60 glasses showed comparable VEGF release as the refer-
ence. Interestingly, the VEGF secretion from 0.01 wt/vol% dilution of
CuSr-1 and CuSr-2.5 was significantly higher than the values of the ref
Fig. 7. Quantification of VEGF in pg/ml released by ST-2 cells after 24h of incubation
with B60, CuSr-1 and CuSr-2.5 particles at different concentrations. Asterisks denote sig-
nificant difference compared with 1 wt/vol% concentration, ***p<.001 (Tukey test was
used).
erence and the B60 sample. The other two dilutions (1 and 0.1 wt/vol%)
of CuSr-1 and CuSr-2.5 showed a decline in VEGF release.
4. Discussion
Two mesoporous silica glasses, CuSr-1 and CuSr-2.5, containing si-
multaneously CuO and SrO, were prepared. The glass characterization
showed that Cu⁠2+ and Sr⁠2+ ions behave as network modifiers. In this
way, they can exert their positive biological action, which is the rea-
son why they were included in the glass. Moreover, Cu and Sr-contain-
ing glasses exhibited moderate textural properties and worm-like meso-
pores arrangement. However, BET surface areas close to 200m⁠2/g and
volumes of pores around 0.30cm⁠3/g were high enough to permit signif-
icant surface reactivity when the glasses were investigated in cell cul-
ture.
In this sense, the synthesis of porous silica-based glasses doped with
biologically active ions is gaining popularity among researchers [6, 7,
16, 17, 19–27, 40, 44–46]. Copper is one such ions which has been
known for more than two decades to play a significant role in an-
giogenesis [24–27, 47]. Rabbits with copper-deficiency were unable to
produce an angiogenic response regardless of the type of angiogenic
stimulus applied [48]. Notable amounts of cellular copper have been
found in human endothelial cells when they were induced to undergo
angiogenesis [47]. In recent years, copper has been incorporated into
bioactive glasses in the form of scaffolds, particles and fibers for sev-
eral biomedical applications [7, 19, 25–27, 49, 50]. On the other hand,
strontium is considered as a promising agent in treating osteoporosis
[20, 21, 23, 51, 52]. Moreover, Marie et al. reported the therapeutic
capability of strontium in bone regeneration in vivo [53, 54] and a
Sr-based drug called strontium ranelate has beneficial effects in bone
healing [55]. In this study, different concentrations of Cu and Sr were
added to the base BG composition SiO⁠2–CaO–P⁠2O⁠5 (Table 1) and new
BG CuSr-1 and CuSr-2.5 were synthesized. The 1 and 0.1 wt/vol% con-
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cells. This could be due to the rapid release of copper and strontium ions
into the solution, which ultimately increases the pH of the medium and
kills the cells. However, the VEGF secretion was found to be the highest
for the Cu and Sr containing glasses (0.01%). Since the cells were neg-
atively affected by the release of ions, the 1 and 0.1 wt/vol% dilutions
of CuSr-1 and CuSr-2.5 showed a decreased VEGF release. It is also im-
portant to note that the experiment was carried out in static conditions
and considering the dynamics of the reactions occurring in vivo, these
compositions of glasses could bring out favorable cell biology results.
As mentioned above, these elements (Cu, Sr) have been indepen-
dently incorporated in other bioceramics. For instance Sr has been fre-
quently included in calcium phosphates [56–58]. In this sense Sr-sub-
stituted hydroxyapatite materials were shown to promote the prolifera-
tion, osteogenic differentiation and angiogenic factor (VEGF) expression
of human osteoblast-like cells [56]. Moreover, scaffolds based on cal-
cium phosphate bioceramic containing Sr could apparently accelerate in
vivo segmental bone regeneration through stimulating VEGF secretion
from osteoblasts in rabbits [57]. Lin et al. further showed that Sr and Si
ions released from Sr-substituted calcium silicate bioactive ceramic scaf-
folds acted synergistically to stimulate the osteogenic differentiation of
MSCs and angiogenesis of umbilical vein endothelial cells in vitro, pro-
moting bone regeneration and angiogenesis in a critical-sized calvarial
defect model of ovariectomized rat [58].
On the other hand, several authors demonstrated that the release of
copper ions stimulates the expression of proangiogenic factors such as
VEGF and transforming growth factor-β (TGF-β) in wounds created in
diabetic mice [59, 60]. Subcutaneous implantation of borate bioactive
glass with copper microfibers in rats significantly enhanced the growth
of capillaries and small blood vessels when compared to silicate 45S5
bioactive glass microfibers [49]. The ionic dissolution product of Cu
doped borate bioactive glass microfibers has been shown to stimulate
the expression of angiogenic genes of fibroblasts in vitro and angiogen-
esis in full-thickness skin wounds in rodents in vivo [49]. Moreover Cu
doped borosilicate bioactive glass scaffolds have been reported to en-
hance blood vessel formation and bone regeneration in vivo in rat cal-
varial defects [27].
Our study has shown for the first time the promising effect of si-
multaneously using Cu and Sr, elements that, given their great angio-
genic and osteogenic potential, were previously independently incorpo-
rated in different bioceramics. Further detailed analysis of the ion re-
lease from these new MBGs and the study of the long-term influence of
the release kinetics on the osteogenic differentiation potential and an-
giogenic capability of B60, CuSr-1 and CuSr-2.5 glasses will be carried
out.
5. Conclusions
Particles (<32μm) of porous bioactive glasses with composition 60-
SiO⁠2–(36-2x)CaO–4P⁠2O⁠5–xCuO–xSrO (x=0, 1 or 2.5mol-%) denoted as
B60, CuSr-1 and CuSr-2.5, respectively, were synthesized. The disso-
lution products from CuSr-1 and CuSr-2.5 produced high VEGF secre-
tion from ST-2 cells after 48h of incubation, highlighting their angio-
genic effect in relation to the combination of an angiogenic stimulator,
Cu, and an osteogenic stimulator, Sr. These glasses showed specific sur-
face areas between 155 and 210m⁠2/g and pore volumes between 0.29
and 0.40cm⁠3/g. In addition, the CuO and SrO additions decreased the
glass network connectivity in CuSr-1 and CuSr-2.5 compared to the un-
doped bioactive glass. These structural features enabled the effective
leaching of Cu⁠2+ and Sr⁠2+ ions into the liquid medium. In the in vitro
cell culture study, dilutions of CuSr-1 and CuSr-2.5 particles of 0.01
wt/vol% did not affect ST-2 cells morphology leading to the highest
VEGF secretion. However, for particle concentrations of 0.1 wt/vol% or
higher, cytotoxic effects were observed. The study has shown that the
combination of Cu⁠2+ and Sr⁠2+ ions leads to bioactive glasses with an-
giogenic character and potential application in bone regeneration appli-
cations.
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